FDA places new restriction on Johnson & Johnson COVID-19 vaccine
Headline from 12News Phoenix
The FDA said it decided to restrict Johnson & Johnson's COVID-19 vaccine after taking another look at data on the risk of life-threatening blood clots.
12News Phoenix's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
The FDA said it decided to restrict Johnson & Johnson's COVID-19 vaccine after taking another look at data on the risk of life-threatening blood clots.
The Food and Drug Administration said Thursday it is limiting the use of the COVID-19 vaccine from Johnson & Johnson to adults who cannot access another version or might face a medical issue if they take another type.
The Food and Drug Administration said the shot should only be given to adults who cannot receive a different vaccine or specifically request J&J's vaccine.
The FDA revised its emergency authorization to sharply limit the use of Johnson & Johnson's COVID-19 vaccine due to a rare but potentially fatal blood clotting condition called thrombosis with thrombocytopenia syndrome (TTS).
The vaccine is still available under emergency use authorization, and the CDC has already made a preferential recommendation for the mRNA vaccines over J&J’s.
FRIDAY, May 6, 2022 (HealthDay News) -- Citing the accumulated data on a raised risk for thrombosis with thrombocytopenia syndrome (TTS), the U.S. Food and Drug Administration on Thursday greatly
The FDA announced it was limiting access to Johnson & Johnson’s Covid-19 vaccine because of the risk of a clotting disorder that was discovered weeks after the vaccine was first put into use in the spring of 2021.
The chances of dying following after receiving the Janssen vaccine is about 1:2,000,000. But with multiple COVID-19 vaccines available, the FDA is limiting the use of the J&J vaccine.
The agency said Thursday that it was making the move after confirming a total of 60 cases, including nine deaths, of the clotting condition known as thrombosis with thrombocytopenia syndrome, or TTS,...
The US said Thursday only adults who "have personal concerns" about mRNA vaccines, access issues or medical reasons for refusing them may now receive the Johnson & Johnson Covid shot, which has been…
U.S. regulators on Thursday strictly limited who can receive Johnson & Johnson’s covid-19 vaccine because of the ongoing risk of rare but serious blood clots.
The Food and Drug Administration narrowed its use authorization for Johnson & Johnson’s single-dose COVID-19 vaccine due to risks of severe blood clotting, a move that comes months after an initial warning from health officials.
